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Clinical Leadership Theme 
 The clinical leadership theme for my project is focusing on improvement of patient safety 
and improving quality of patient care. Reducing the IV infiltrate rate in the neonatal population 
in the Neonatal Intensive Care Unit (NICU) is a valuable area to focus improvement of care. 
Lake and Beecroft (2010) say that of patients having IV therapy approximately 10% to 20% will 
have IV infiltrate complications. It is important to develop strong core values and competencies 
that are going to help mold and support this project which include communication, teamwork, 
decision making, research process, conflict management, staff development and mentoring. 
(Nursing Times, 2013) The contribution of the role the leadership and competencies will provide 
is a structured framework and consistent data collection and project approach which will help 
with the success of the project outcome. “Competent nursing and effective leadership are 
fundamental to the provision of high-quality care” (Nursing Times, 2013). 
Statement of the Problem 
 Infiltrates are a rising problem in our neonatal population in the Neonatal Intensive Care 
Unit (NICU). Wilt & Huey (2016) states that the Institute of Medicine (IOM) “aims of safe, 
efficient, effective, and patient-centered care by focusing on improvement efforts in the pediatric 
patient receiving IV therapy.” The NICU, including myself, formed an auditing committee to 
identify reoccurring problems that may account for infiltration. Prior to the IV infiltrate auditing 
committee the NICU experienced twenty-one out of the fifty-four infiltrate occurrences from 
actively running IV lines making the rate at almost 39%.  A few questions that our auditing 
committee has included are: Are IV infiltrates being documented correctly? What are the reasons 
IV infiltrate rates are at 39%? Is there an opportunity for staff education and development? What 
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changes can be implemented to decrease infiltrates? What outcomes and results do we anticipate 
or would like to see? 
Project overview 
 The major goal of the project is to reduce the number of IV infiltrates and reduce the 
severity of each of the infiltrates by auditing all running IV lines, infiltrates and IV management 
and infiltration documentation. This goal aims to improve patient safety and the quality of care 
given to the patient. “Infiltration is the most common complication associated with PIV use in 
infants, accounting for 23-78% of complications.” (Driscoll, MD, Langer, Burke, & El 
Metwally, MD, 2015) The NICU developed an auditing committee that will be conducting 
auditing of all running IV therapy lines and all IV infiltrates. This auditing will be used to 
formulate accurate data as to the common causes of infiltrates in the neonatal population. After 
approximately a year of auditing changes formulated to the causes will be developed and 
implemented. After the implementation of the changes, auditing will continue to monitor if 
improvement is seen.  
When our project began our auditing data was inaccurate due to under documentation and 
errors in staging the infiltrates. According to Lo (2014) correct documentation results in 
improved patient safety. Due to the inaccuracy in our data our team has had to provide bedside 
training and education to all staff members with emphasis on the nurses that experienced 
infiltrate occurrences. The NICU auditing committee is focusing on a few key elements to add to 
our project, these include: where is the IV located? How long has the IV been in place? What 
was running through the line and at what rate? 
  The specific aim statement is to reduce IV infiltrates rates and severity of infiltrates in 
the neonatal population. A reduction of 20% or more from the baseline of 2.12 to decrease  to a 
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rate of 1.70 incidents of infiltrate in the first six months through auditing all therapeutic IV lines 
and infiltrate occurrences. The specific aim statement is similar to the global aim statement as it 
narrows down a goal and objective from the global statement. My global aim statement focuses 
on the improvement of patient safety and quality of care given to our neonates.  
Rationale 
 The NICU’s Clinical Nurse Specialist (CNS) started receiving data on one of our unit’s 
problems in patient safety revealing that IV infiltrate rates began to rise and the grades of 
infiltrates were getting worse. “PIV catheter is the most used vascular access device for the 
administration of medications in hospitalized neonates” (Beall, Hall, Mulholland, & Gephart, 
2013). This new data sparked the NICU’s administration to formulate a committee of volunteers 
NICU nurses to gather together and find out what is causing the increase in rates. In just a few 
short months the CNS discovered that there was a significant jump in the severity of infiltrates 
resulting in severe skin necrosis that required in-depth treatment for our already critical neonates.  
 Before our auditing began our unit had ten grade 1, eight grade 2 and three grade 3- 4. 
The month of January the data resulted at two grade 1 eight grade 2 and five grade 3-4. The 
month of March resulted in twelve grade 1, five grade 2 and fifteen 3-4. The rates have 
fluctuated since the project has begun and a definitive cause has yet to stir the group into making 
any changes based on our data.  
There are four different grades and each are dependent on site and degree infiltration. 
Grade one includes pain at the site but is not accompanied by swelling or erythema. Grade two 
includes pain at the site and limited swelling. Grade three includes pain at the site, moderate 
swelling, cool skin and skin blanching. The last and most severe grade four includes pain at the 
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site, severe swelling, cool and blanching skin, decreased or absent pulses, increased capillary 
refill and skin breakdown or necrosis. (Massey & Clinical Practice Committee, 2010)  
 The projected cost analysis is wage for all ten staff included in the auditing. See 
Appendix A for a projected cost analysis. The staff is paid in addition to their normal work shifts 
and each meeting lasts approximately two hours and is roughly held six times a year. If each 
nurse makes approximately $32 an hour and this meeting is overtime, it makes the wage time 
and a half equaling out to $48 an hour. If ten nurses are paid at least two hours of overtime at six 
times a year and the project is estimated three years that would put our total at approximately 
$17,280.  
The staff education and training that is provided as well as all auditing is accomplished 
while each committee member is working their normal shift. This eliminates the extra cost in 
data collection and staff development. There will however, be future cost for the changes that 
will be implemented once the evaluation process is done. There are costs that will be saved if the 
project is a success and the infiltration rates decrease. Major and Huey (2016) states that an 
approximate IV infiltrate cost is $500 per patient per incident. The unit will also save in 
treatment such as Hyaluronidase- a medication to decrease the fluid that infiltrated into the skin- 
which costs our facility $40 per dose to administer. The unit will have a decrease in costs of 
supplies such as heat packs to reduce the swelling, needles and syringes to administer the 
Hyaluronidase. See Appendix B for the Root Cause Analysis (Fishbone Diagram). See Appendix 
C for the Process Map (Flow Chart). See Appendix D for the SWOT Analysis. See Appendix E 
for the Stakeholder Analysis. 
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Methodology 
 The approach being taken is to audit the IV lines to narrow down causes of the infiltrates. 
After the causes are narrowed down, then the process will be to develop a plan of action and 
changes that should be implemented. The objective with auditing gives us the ability to have real 
and current data and statistics for our infiltrate rates.  
The committee is focusing on a few key elements to add to our auditing these include: 
where is the IV located? How long has the IV been in place? What was running through the line 
and at what rate? “Vesicants are substances capable of causing inflammation, pain, and blistering 
of tissues leading to tissue death and necrosis” (Lake & Beecroft, 2010). Is the nurse doing 
hourly checking and how is the checking being completed? Lastly, how is the site secured? All 
of these questions will help us narrow down what might be some of the top concerns that the 
committee might focus on.  
The change theory that has can be closely followed with what we are doing is Lewin’s 
Change Theory. The first step is preparing the change that is about to take place or “Unfreezing.”  
The preparation of the staff for change was implemented last year before the auditing committee 
first began. The second step is “Change” the process the project is currently in with the auditing 
and finding possibilities for change. The last and final stage is “Refreeze” where the changes are 
implemented and stability is attempted. (MindTools, 2016) 
Since the project is currently still in the process of being audited and there have not been 
changes that have been implemented, it will not be clear if the project is completely effective. 
The data that is currently being gathered is showing that there is a growing amount of numbers 
of all staging of IV infiltrates. However, this may be due to the staff education and training that 
is being provided on the correct documentation and staging of infiltrates. 
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Currently the committee is gathering the results of the data to try and see a reoccurring 
pattern of issues for causes of infiltrates. If common causes of infiltrates can be identified, then 
the group can begin to focus on the development of ideas for change. After change has been 
made the results will come when the infiltrate rates begin to improve and the infiltrate become 
less severe.  
One way to check if the change that has been implemented had any effect would be 
finding a decrease in the IV infiltrate rates and the severity of the infiltrate when they do occur. 
My prediction is that our infiltrate rates will decrease and the severity of each infiltrate will get 
better. However, due to the fragile nature of the neonate’s vascular system I do feel that it will be 
nearly impossible to completely eliminate the less severe grades completely. IV sites can 
infiltrate so quickly and if the nurse is assessing the site appropriately and frequently the site 
might already have infiltrated as soon as the nurse checks the site. The goal of the project is to 
reduce the infiltrates and damage to the neonate. 
Data Source/Literature Review 
 The focus of the study is to improve patient safety and improve patient care. It was found 
that “95% of PIV catheters are removed due to complications” (Beall, Hall, Mulholland, & 
Gephart, 2013). This can prove that if an IV was left in and a complication was not caught, then 
how many potential complications might this cause the patient? Our team felt that auditing 
would provide us with the best data and statistics to formulate our conclusions on. Once the 
conclusions are formulated than change that is specified for the problem areas can be developed.  
 The materials that were used in my project outline aided in supporting the importance of 
focusing on reducing infiltrates, correct staging and suggested changes such as various 
securement devices. Wilt & Huey (2011) states that staff education and training helped with the 
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success rate of decreasing infiltrates by almost 8% in the first 24 hours and an improvement of 
almost 53% over a three-month span.  
Since we are auditing the length of time the IV has been in place there have been studies 
that show that a length of over 72 hours increases the risk of skin necrosis and breakdown. 
(Garland, Dunne, Havens, Hintermeyer, Bozette A., et all, 2002) Studies also show that 
“extravasation of fluid, a common complication of IV therapy, can cause significant and long-
lasting sequelae…” (Khan et al., 2014).  
The concern is damage to the nerves since neonates have a fragile vascular system and 
nervous system if the infiltrate is severe enough it might cause lasting damage. According to 
Beall, Hall, Mulholland & Gephart (2013) “Infiltration and extravasation are one of the most 
destructive complications to the neonate’s fragile skin”. According to Irving (2001) common IV 
sites include: the dorsum in the hand and foot, basilica or cephalic veins, dorsal venous arch and 
the lateral marginal vein. Irving (2001) goes on to say these sites the most common for ease of 
access for viewing and ease of starting. However, these sites can cause the most tissue damage or 
damage to the nerves or tendons possibly causing long term damage and or loss of joint 
movement.    
 My PICO statement includes: P- Neonatal population which includes neonates that range 
from 23 weeks corrected gestational age and older. “The preterm and sick neonate is more 
susceptible to skin injury and complications from extravasation injury than their mature, healthy 
counterparts” (Beall, Hall, Mulholland & Gephart, 2013) I- Auditing and monitoring IV lines in 
the neonates to develop changes to decrease infiltrates. C- Currently there are high infiltrate rates 
with varying grades of severity to the neonate. O- The desired outcome is to decrease infiltrate 
rates, decrease harm to the neonate and improve the quality of care and safety given to the 
Reducing Infiltrate in the Neonatal Population                                                                             9 
 
neonate. “Serious complications are not entirely preventable, but following recommended 
standards of IV therapy is the best approach for avoiding complications” (Beall, Hall, 
Mulholland & Gephart, 2013). All of the literature supports the PICO statement by showing the 
importance of maintaining a safe and patent IV line.  
Timeline 
There are several grades for this project to be complete. The project start date is March of 
2015 and there is roughly three years of planning, auditing, change implementation, staff 
education and evaluation. 
 The first stage was to identify the problem and need. The second stage is to audit for 
accurate data pertaining to the infiltrates. The next step is to interpret the data collected and 
formulated ideas that can be implemented. The last stages include implementing the changes, 
educating the staff on the new changes and re-evaluating if the changes that took place improved 
the rates. See Appendix F.  
Since the problem was already identified the project moved to the auditing stage. The 
timeline for auditing is a least one year. The project goal is to have accurate infiltrate data 
including correct staging of the infiltrate, correct and complete documentation and staff 
education and training. The reason our auditing committee agreed on a longer timeline was due 
to the lack of knowledge in the staff for correct documentation, infiltrate staging and recognizing 
that an infiltrate is occurring. For these reasons our group wanted to audit and provide staff 
education with a re-evaluation during the research process.  
Expected Results 
 It is expected that after the auditing stage is complete and a plan is set to that infiltrate 
numbers will decrease. Currently, our data is showing that there are some problems in location 
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and securement of the IV and the fluids that are running through the line. The belief is that once 
these problems are addressed it can have a huge impact on IV infiltrates.  
Nursing Relevance 
 It is strongly believed that this will help not only with our other units in our facility but 
with other facilities as well. Our IV auditing is currently branching out into other units and other 
facilities want to know what changes we make so they might implement those changes in their 
facilities. Other units in our facility have contacted the NICU asking if the committee would 
begin auditing all other units because the infiltrate rates are increased facility wide. There is 
currently no specific data that was given to the NICU’s auditing committee to support an 
increased rate. Each unit has their data and will provide it to the NICU within the next few 
months after auditing comes to a close in the critical care. This project could potentially make a 
positive impact on not only our NICU but other units and other facilities.  
Summary Report 
  During this project to decrease IV infiltrates in the neonatal population I was actively 
involved in monthly meetings with the committee by presenting auditing data, sharing ideas for 
changes and assisting in the development of the committee. I completed continuous auditing 
during my shift as a bedside RN and during my practicum hours. I provided education and 
training to all bedside nurses that experienced an infiltrate as well as assisted with proper 
infiltrate staging and documentation. I am participating in the trials of the new IV securement 
dressing that we are implementing.  
   The specific aim statement is to reduce IV infiltrates rates and severity of 
infiltrates in the neonatal population. A reduction of 20% or more from the baseline of 2.12 to 
decrease 1.70 incidents of infiltrate in the first six months through auditing all therapeutic IV 
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lines and infiltrate occurrences. The specific aim statement is similar to the global aim statement 
as it narrows down a goal and objective from the global statement. My global aim statement 
focuses on the improvement of patient safety and quality of care given to our neonates. 
 The population that was involved in this project included 23 weeks gestational age and 
older in the Neonatal Intensive Care Unit (NICU) at Valley Children’s Hospital.  
 Prior to the auditing process beginning we prepared the staff that a committee would be 
monitoring and become involved in IV infiltrates. After we prepared the staff the committee we 
began nightly auditing and monthly meetings. Recently, a new securement dressing is being 
introduced to assist in supplying stability and visibility to the IV site. The hope is that a 
uniformed and standardized dressing will eliminate the inability to see the site or the variations 
in IV securement with each nurse having their own way to secure the site. Since the new 
securement dressing has just been introduced we do not have any data that shows any 
improvement with this change.  
 The NICU’s baseline data prior to the start of the project showed ten grade 1, eight grade 
2 and three grade 3- 4. This data results in high grade 1 and 2 and lower grade 3 and 4 showing 
the need to reduce these incidents.  
 A few members from the committee made poster boards to be taken to the bedside for 
training and education for the staff. The boards included each grade of infiltrate, pictures of each 
grade, methods to reduce infiltrate such as hourly checking, treatments for infiltrates and what 
documentation needs to be filled out if an infiltrate does occur. This board acts as a resource for 
each nurse who might have questions about IV site management or infiltrate management. It has 
helped with increasing awareness to the staff with visual and verbal education. 
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 Currently, the NICU is not meeting the goal of a 20% reduction from the baseline. The 
data collected from March 2016 showed that the infiltrate/extravasation rate per 1000 patient 
days was 9.66 and our projected goal was 1.70 for grades 3 and 4. March has a total of thirty-two 
infiltrates which resulted in twelve grade 1, five grade 2, fourteen grade 3 and one grade 1. See 
Appendix G for our evaluation tools and data collected during the project. 
  The plan to provide sustainability includes continuing the auditing process to insure the 
change that was implemented with the new securement dressing will improve infiltration rates. 
Sustainability also needs continued training and education to staff that cover how to provide 
proper IV management, grading infiltrates and proper documentation. Another plan our 
committee has suggested is providing resources, other than the educational boards, such as 
nurses and policy changes to help provide information or feedback to staff with questions to help 
maintain a standardized level of care. The goal of providing the staff with support, resources and 
continual education and training is to maintain ongoing development and to insure that policy 
and standardization is up held. Once a permanent change has been proposed, standardized and 
implemented sustainability is obtained through repetition and a strong support system. Quality 
improvement is key focus and with a reduction in IV infiltrates this can be reached.  
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Appendix A 
Cost Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
Major and Huey (2016) states that an 
approximate IV infiltrate costs $500 per 
patient per incident. The unit will also 
save in treatment such as Hyaluronidase, 
a medication to decrease the fluid that 
infiltrated into the skin, which costs our 
facility $40 per dose to administer.
Per Nurse
$32/hr for regular shift in the NICU
$48/hr for overtime
$96 per meeting of 2 hours.
$576 for six meetings a year
$1728 for the projected three years
For ten nurses this would be $17,280  
Future cost for the changes that will be 
implemented once the audiditing process 
and data collection is done. 
Staff education and development would 
be conducted by the group while they 
were working a normal shift.
Cost Analysis
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Appendix B 
Root Cause Analysis (Fishbone Diagram) 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Poor quality of care 
and impaired 
patient safety due 
to increased IV 
infiltrate rates.  
Staff 
Resources 
Education 
Standardization 
Inaccurate or 
incomplete charting 
done  
Lack of staff education and 
development on proper documentation 
and infiltrate staging.   
Minimal availability 
to resources for PIV 
infiltration.   
No standardization for securing 
the IV site or dressing.   
No standardization for recommended 
IV location or length of time the 
catheter should remain in place.   
High number of new 
graduate nurses and new 
staff to the NICU. 
Lack of knowledge and understanding on the 
importance of IV assessments due to new 
graduate nurses and new staff to the NICU.   
Facility’s policy does not 
clearly define IV management 
or stages of infiltrates.  
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Appendix C 
Process Map (Flow Chart) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identify Problem of 
increasing rates of PIV 
infiltrates.
Formulate a plan to 
gather data by involving 
staff in an auditing 
committee. 
Audit all running IV 
lines, infiltrates and 
documentation.
Staff education and 
training on proper IV 
management, infiltrate 
staging and correct 
documentation.
Idendify key factors that 
are causing the 
infiltrates.
Formulate changes and 
provide staff education 
on upcoming changes. 
Implement changes and 
provide various 
resources for staff. This 
time auditing will 
continue.
Evaluate the effect of the 
changes.
If changes have improved 
IV infiltrates rates and the 
improvement goal has been 
met than a policy needs to 
be created.
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Appendix D 
SWOT Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strengths
- Committed auditing team
- Drive to improve patient safety and 
care
Weaknesses
- Non-compliance from bedside nurses 
to maintain patent IV access.
Opportunities
- Creating an opportunity for outside 
partnership with fellow NICUs from 
other facilities on ways to reduce 
infiltrates.
Threats
- Product availability and affordability 
for supplies that our unit might want to 
trial.
SWOT
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Appendix E 
Stakeholder Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reliability and longevity of 
the staff in the IV infiltrate 
committee. 
Bedside nurses’ ability to 
adapt to change. 
Adequate and thorough staff 
education and training while 
in the auditing process.  
Accurate data collection and 
auditing for later study. 
Improvement in IV infiltrates 
Data 
collection 
and 
auditing  
Adequate 
Inadequat
e 
No Improvement  Improvement  
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Appendix F 
Projected Timeline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stage 1
• by March 2015 
• Identify the problem and need. 
• Staff include: CNS, NICU Administration, 10 to 20 NICU staff nurses
Stage 2
• April 2015
• Begin auditing for accurate data pertaining to the infiltrates
• Staff include: Nurse Manager (Lead), 10 NICU staff nurses and all bedside 
nurses
Stage 3
• Projected end date June 2016
• Interpret the data collected and formulated ideas that can be implemented
• Staff include: Nurse Manager (Lead), 10 NICU staff nurses
Stage 4
• Projected end date for the entire project June 2018
• implementing the changes, educating the staff on the new changes and re-
evaluating if the changes that took place improved the rates.
• Staff include: Nurse Manager (Lead), 10 NICU staff nurses and all bedside 
nurses
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Appendix G 
Evaluation Tools and Data Collected  
 
 
 
Evaluation 
Tools and Data 
Collected
Audit documentation 
in the EMR and IV 
infiltrates
Comparing data 
from previous 
months' data
Bar graph showing 
comparative results 
of each month
Stage infiltrate 
through proper 
infiltration 
documentation in the 
EMR.
Audit all running 
IV therapy lines
